As of September 2024, Purple Biotech has a market cap of $9.19M. This makes Purple Biotech the world's 32591th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $19.11M | -8.78% |
2023 | $20.95M | -37.70% |
2022 | $33.63M | -57.15% |
2021 | $78.48M | -4.63% |
2020 | $82.29M | -50.84% |
2019 | $167.41M | -1.20% |
2018 | $169.45M | -67.09% |
2017 | $514.90M | -34.12% |
2016 | $781.55M | -1.49% |
2015 | $793.37M | -60.29% |
2014 | $2.00B | -85.45% |
2013 | $13.73B | -19.60% |
2012 | $17.08B | -23.08% |
2011 | $22.20B | -56.67% |
2010 | $51.23B | -38.78% |
2009 | $83.67B | -3.92% |
2008 | $87.09B | -95.04% |
2006 | $1.76T | 0.00% |
2005 | $1.76T | 44.79% |
2004 | $1.21T | -83.35% |
2003 | $7.28T | -64.50% |
2002 | $20.51T | - |